According to our (Global Info Research) latest study, the global Veterinary Maxingshigan Drug market size was valued at US$ 964 million in 2024 and is forecast to a readjusted size of USD 1275 million by 2031 with a CAGR of 4.7% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Veterinary Maxingshigan Drug is a granular veterinary traditional Chinese medicine (TCM) formulation derived from the classical prescription "Maxing Shigan Tang," composed of four herbal ingredients: Ephedra (Ma Huang), Bitter Apricot Seed (Xing Ren), Gypsum (Shi Gao), and Licorice (Gan Cao). It functions to clear heat, detoxify, and relieve lung congestion, making it effective against respiratory diseases such as cough, asthma, bronchitis, and pneumonia in livestock (e.g., pigs, cattle, sheep) and pets (e.g., dogs, cats) caused by wind-heat invasion or lung heat syndrome. The granules are produced using modern extraction and concentration techniques for easy administration. Its therapeutic mechanisms include pathogen inhibition, anti-inflammatory effects, expectorant action, and immune modulation, reducing reliance on antibiotics. As a natural and convenient alternative, Veterinary Maxingshigan Granules align with antibiotic-free farming and sustainable animal husbandry practices.
This report is a detailed and comprehensive analysis for global Veterinary Maxingshigan Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Veterinary Maxingshigan Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Veterinary Maxingshigan Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Veterinary Maxingshigan Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Veterinary Maxingshigan Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Veterinary Maxingshigan Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Veterinary Maxingshigan Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bolai Yaoye, Anhui Wanshi Biopharmaceutical, Tsumura, Harbin Qianhe Animal Drug Manufacturing, Wuhan Huisheng Biotechnology, Puyer International Group, Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering, China Animal Husbandry Industry, Runda Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Veterinary Maxingshigan Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Maxingshigan Granules
Maxingshigan Oral Liquid
Market segment by Application
Pig
Chicken
Dog
Others
Major players covered
Bolai Yaoye
Anhui Wanshi Biopharmaceutical
Tsumura
Harbin Qianhe Animal Drug Manufacturing
Wuhan Huisheng Biotechnology
Puyer International Group
Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering
China Animal Husbandry Industry
Runda Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Veterinary Maxingshigan Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Veterinary Maxingshigan Drug, with price, sales quantity, revenue, and global market share of Veterinary Maxingshigan Drug from 2020 to 2025.
Chapter 3, the Veterinary Maxingshigan Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary Maxingshigan Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Veterinary Maxingshigan Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Maxingshigan Drug.
Chapter 14 and 15, to describe Veterinary Maxingshigan Drug sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Veterinary Maxingshigan Drug. Industry analysis & Market Report on Veterinary Maxingshigan Drug is a syndicated market report, published as Global Veterinary Maxingshigan Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Veterinary Maxingshigan Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.